SCHEMBL358162

SCHEMBL358162

CCCCCCC=CCCCCCCC(CC)C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.66
MAPK1 P28482 1/20 0.66
TERT O14746 3/20 0.55
PTPN1 P18031 3/20 0.55
PPARG P37231 3/20 0.55
PPARD Q03181 3/20 0.55
PPARA Q07869 3/20 0.55
TOP1 P11387 3/20 0.55
MAPT P10636 2/20 0.55
BLM P54132 2/20 0.55
HSD17B10 Q99714 2/20 0.55
FABP4 P15090 2/20 0.55
GMNN O75496 1/20 0.55
USP2 O75604 1/20 0.55
LMNA P02545 1/20 0.55
CYP1A2 P05177 1/20 0.55
POLB P06746 1/20 0.55
CYP2C9 P11712 1/20 0.55
ALOX15 P16050 1/20 0.55
APEX1 P27695 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL358160 1.00 CA2 (0.66) CA2MAPK1TERTPTPN1PPARG
SCHEMBL1015155 1.00 CA2 (0.66) CA2MAPK1TERTPTPN1PPARG
SCHEMBL1116087 1.00 CA2 (0.66) CA2MAPK1TERTPTPN1PPARG
SCHEMBL397443 1.00 CA2 (0.66) CA2MAPK1TERTPTPN1PPARG
SCHEMBL11301832 1.00 CA2 (0.66) CA2MAPK1TERTPTPN1PPARG
SCHEMBL11301839 1.00 CA2 (0.66) CA2MAPK1TERTPTPN1PPARG
SCHEMBL3022238 1.00 CA2 (0.66) CA2MAPK1TERTPTPN1PPARG
SCHEMBL28430518 0.96 CA2 (0.66) CA2MAPK1TERTPTPN1PPARG
SCHEMBL10906977 0.95 CA2 (0.59) CA2MAPK1PPARGPPARDPPARA
SCHEMBL10906974 0.95 CA2 (0.59) CA2MAPK1PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-61293501-A None JP disclosed
US-20250376427-A1 COMPOSITIONS AND METHODS FOR THE PURIFICATION OF SQUALENE AMYRIS INC (US) 2025-12-11 US disclosed
EP-4544069-A1 COMPOSITIONS AND METHODS FOR THE PURIFICATION OF SQUALENE Amyris, Inc. (US) 2025-04-30 EP disclosed
WO-2023250129-A1 COMPOSITIONS AND METHODS FOR THE PURIFICATION OF SQUALENE Amyris, Inc. (US) 2023-12-28 WO disclosed
CN-113150899-A Mixed fermentation process based on yeast Papiliotrema laurentii and saccharomyces cerevisiae 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) 2021-07-23 CN disclosed
CN-113150897-A Mixed fermentation process based on meiji yeast and saccharomyces cerevisiae 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) 2021-07-23 CN disclosed
CN-112812980-A Mixed fermentation process based on Hansenula polymorpha and saccharomyces cerevisiae 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) 2021-05-18 CN disclosed
EP-2845897-B1 Microorganisms with extended substrate utilization range NESTE OYJ (FI) 2018-08-22 EP disclosed
CN-105145557-B A kind of citrus fruit fly sex pheromone 华中农业大学 2017-10-17 CN disclosed
US-9497973-B2 Elasmobranch-repelling compounds, methods of use and devices STROUD ERIC MATTHEW (US) 2016-11-22 US disclosed
EP-2593540-B1 MICROORGANISMS WITH EXTENDED SUBSTRATE UTILIZATION RANGE NESTE OIL OYJ (FI) 2016-03-23 EP disclosed
CN-105145557-A Sex pheromone of bactrocera minax UNIV HUAZHONG AGRICULTURAL 2015-12-16 CN disclosed
US-8986960-B2 Microorganisms with extended substrate utilization range NESTE OIL OYJ (FI) 2015-03-24 US disclosed
EP-2845897-A1 Microorganisms with extended substrate utilization range Neste Oil Oyj (FI) 2015-03-11 EP disclosed
EP-2593540-A1 MICROORGANISMS WITH EXTENDED SUBSTRATE UTILIZATION RANGE Neste Oil Oyj (FI) 2013-05-22 EP disclosed
US-20120015413-A1 Microorganisms with Extended Substrate Utilization Range NESTE OIL OYJ (FI) 2012-01-19 US disclosed
WO-2012007646-A1 MICROORGANISMS WITH EXTENDED SUBSTRATE UTILIZATION RANGE NESTE OIL OYJ (FI) 2012-01-19 WO disclosed
US-20100203154-A1 Elasmobranch-Repelling Compounds, Methods of Use and Devices STROUD ERIC MATTHEW 2010-08-12 US disclosed
JP-S61293501-A EXTRACTING METHOD FOR FRAGRANT SUBSTANCE KIKKOMAN CORP 1986-12-24 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100203154-A1 Elasmobranch-Repelling Compounds, Methods of Use and Devices ELOC, ELOVL3, ELOVL6 CA2 1711/4885MAPK1 4728/4885TERT 3200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.